BMS Receives FDA Review for Anemia Therapy Expansion
Bristol Myers Squibb (BMS) has been granted FDA review for a label expansion of its anemia therapy, developed in partnership with Merck.
Results for "Bristol Myers Squibb (BMS)"
3 stories found
Bristol Myers Squibb Discusses Immuno-Oncology in Cyprus
Bristol Myers Squibb (BMS) held a press conference in Cyprus where medical oncologists highlighted the value of immuno-oncology and key factors for improving cancer patient care.
China's Hengrui Pharmaceutical Seals US$15.2 Billion Deal with Bristol Myers Squibb
Jiangsu Hengrui Pharmaceutical, China's largest drug company, has entered into a global collaboration and licensing agreement with US pharmaceutical giant Bristol Myers Squibb (BMS) valued at up to US$15.2 billion.